Evidence brief · printable

Bipolar Disorder evidence brief

One page, every section sourced. Print it or bring it on your phone.

Print or save as PDF Fits on one A4 or Letter page.

Bipolar Disorder: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/bipolar-disorder.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Aripiprazole 4 trials
  • Lithium 3 trials
  • Bupropion 2 trials
  • Valproate 2 trials
  • Venlafaxine 2 trials
  • Ziprasidone (Geodon) 2 trials

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Transcranial brain stimulation (tDCS, TMS) 49 trials · 25 completed · 13 with results
  • Psychotherapy, counselling and peer support 58 trials · 34 completed · 7 with results
  • Education, coaching and self-management 26 trials · 17 completed · 6 with results
  • Cognitive training and remediation 22 trials · 12 completed · 4 with results
  • Care coordination, navigation and outreach 13 trials · 8 completed · 3 with results
  • Cognitive behavioural and related therapies 49 trials · 30 completed · 2 with results

Natural products (RepurpOS Moderate tier)

Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.

  • Omega-3 Fatty Acids
  • N-Acetylcysteine
  • Coenzyme Q10
  • Ashwagandha
  • Chromium
  • Uridine

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes… NCT06929273
  • Pramipexole vs Placebo Treatment in Bipolar Disorder With Anhedonic Depression NCT07664852
  • A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic… NCT06951711
  • Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization NCT07130500
  • Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive… NCT04296604
  • Characterization of High-Level Cognitive Impairments in Patients With… NCT07295652

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Among 13 trials of care delivery and health services found, none measured cognition 58 trials of other approaches did
  • Among 32 trials of supplements and nutraceuticals found, none measured quality of life 40 trials of other approaches did
  • Among 9 trials of oxygen, light, temperature and manual therapies found, none measured quality of life 40 trials of other approaches did
  • Mind-body and psychological approaches: quality of life 11 trials, no results posted yet
  • Mind-body and psychological approaches: cognition 10 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (473 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.